Please login to the form below

Not currently logged in
Email:
Password:

Kite Pharma names Cynthia Butitta as CFO

She helped broker Pfizer’s takeover of NextWave Pharmaceuticals

Kite Pharma has named industry veteran Cynthia Butitta as chief financial officer.

Butitta was most recently chief financial officer of NextWave Pharmaceuticals and played a key role in the company's acquisition by Pfizer in October 2012.

Her other previous roles include chief financial officer and chief operating officer of Telik where she was responsible for securing over $450m through an initial public offering (IPO). She was also VP of finance at the biotech Connetics.

Kite Pharma is a biotech specialist in the burgeoning area of cancer immunotherapy products.

It has made a number of recent senior appointments in recent months – including several immunotherapy experts to its scientific advisory board and a chief medical officer – and Butitta is the latest hire to bolster its senior team.

“As a leading company in the emerging and highly promising field of immunotherapy, Kite has the opportunity to play a pivotal role in changing the way we approach cancer,” said Butitta.

10th January 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics